A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis
Clinical trial NCT04498403 · TERMINATED
Trial details
- NCT number
- NCT04498403
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2020-12-18
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.